AvKARE recalls Atovaquone Oral Suspension USP, 750 mg per 5 mL sachets, 20 Units x 5 mL cartons, Rx Only, Manufactured for: AvKARE, Pul
Recalled April 24, 2024 · FDA recall D-0444-2024 · AvKARE
Hazard
Microbial contamination of a non-sterile product: potential Bacillus cereus contamination. · FDA Class I
Units
153 cartons
Sold at
US Nationwide.
Description
Microbial contamination of a non-sterile product: potential Bacillus cereus contamination.
Product
Atovaquone Oral Suspension USP, 750 mg per 5 mL sachets, 20 Units x 5 mL cartons, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 50268-086-12.
Manufacturer(s)
AvKARE
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →